Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Prostate cancer metastatic
ADR ID BADD_A03562
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.25      Reproductive neoplasms male malignant and unspecified
16.25.01      Prostatic neoplasms malignant
16.25.01.002      Prostate cancer metastatic
21      Reproductive system and breast disorders
21.04      Prostatic disorders (excl infections and inflammations)
21.04.02      Prostatic neoplasms and hypertrophy
21.04.02.004      Prostate cancer metastatic
Description Not Available
MedDRA Code 10036909
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Adenocarcinoma of the prostate metastatic | Carcinoma of the prostate metastatic | Prostate cancer metastatic | Prostatic cancer metastatic
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00014Abiraterone0.011745%
BADD_D00151Apixaban0.000152%
BADD_D00171Ascorbic acid0.000496%
BADD_D00271Bicalutamide0.009842%
BADD_D00285Bosentan0.000120%
BADD_D00364Carboplatin0.000168%
BADD_D00599Degarelix--
BADD_D00736Dutasteride0.000797%
BADD_D00775Enzalutamide0.001835%
BADD_D00858Everolimus0.000153%
BADD_D00898Finasteride0.000067%
BADD_D01038Goserelin0.001001%
BADD_D01253Lenalidomide--
BADD_D01260Leuprolide acetate0.027964%
BADD_D01393Meropenem0.000049%
BADD_D01498Morphine0.000111%
BADD_D01913Ranitidine0.000038%
BADD_D02026Simvastatin0.000011%
BADD_D02192Thalidomide0.000241%
BADD_D02392Zoledronic acid--
BADD_D02490Apalutamide0.001835%
BADD_D02567Lutetium lu-177 vipivotide tetraxetan-
BADD_D02586Radium ra-223 dichloride-
The 1th Page    1    Total 1 Pages